Sunday, April 5, 2026
ISSN 2765-8767
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us

CDC reports low adverse event rates for vaccines for January 2021

A new report from the US Centers for Disease Control and Prevention (CDC) shows relatively low rates of adverse events from the coronavirus disease 2019 (COVID-19) vaccine.

Overall, between Dec. 14 and Jan. 13 there was more than 13.7 million vaccine doses administered and 6994 reports of adverse events following vaccination. Of the adverse events, 6354 (90.8%) were deemed non-serious and 640 (9.2%) were classified as serious.

To monitor vaccine safety and report adverse events, the CDC relies on the Vaccine Adverse Event Reporting System (VAERS), a spontaneous reporting system and v-safe, an active surveillance system.

Source: Centers for Disease Control

Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Videos

Policy Shift in Peptide Regulation

Semaglutide and the Expansion Problem: When One Trial Becomes a Platform

Semaglutide and the Expansion Problem: When One Trial Becomes a Platform

Semaglutide has moved beyond its original indication and now sits at the center of a widening set of clinical questions: cardiovascular risk, kidney disease progression, and even neurodegeneration. The question is no longer whether the drug lowers glucose or reduces weight—it does—but how far those effects extend across systems, and whether evidence from one population can be translated into another without distortion. Large, well-powered trials have produced consistent signals, yet those signals are now being applied in contexts that were...

Read more

Join Our Newsletter!